Publications by authors named "C Mignosa"
Background: The safety of concomitant percutaneous coronary intervention (PCI) during transcatheter aortic valve implantation (TAVI) setting is still highly debated. This study aimed to assess the safety and the effectiveness of TAVI and PCI performed in the same session compared with TAVI alone.
Methods: Patients with severe aortic stenosis and coronary artery disease (CAD) (N.
Objectives: The aim of this study was to investigate the need for postoperative permanent pacemaker implantation (PPI) following sutureless and rapid-deployment aortic valve replacement (SuRD-AVR) in the context of a progress report from a large multicenter international registry (SURD-IR).
Methods: We retrospectively analyzed 4,166 patients who underwent SuRD-AVR between 2008 and 2019. The primary outcome was the need for PPI before discharge.
Objectives: To compare procedural and in-hospital outcomes of patients undergoing sutureless (Perceval, Livanova PLC, London, UK) and rapid deployment (Intuity Elite, Edwards Lifesciences, Irvine, CA, USA) aortic valve replacement (group 1) versus sutured aortic valve replacement (group 2).
Methods: Patients receiving isolated aortic valve replacement between 2014 and 2020 were analysed using data from the Sutureless and Rapid Deployment International Registry. Patients in group 1 and group 2 were propensity-score matched in a 1:1 ratio.
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a heterogeneous disease with different clinical presentations, albeit producing similar dismal long-term outcomes if left untreated. Several approaches are available for the treatment of HOCM; e.g.
View Article and Find Full Text PDFArticle Synopsis
- A study conducted at a high-volume Italian center assessed changes in transcatheter aortic valve implantation (TAVI) practices and patient outcomes from June 2007 to August 2021, categorizing data into four time periods.
- The analysis included 2058 patients with a mean age of 82, revealing a decrease in mortality risk and significant reductions in in-hospital deaths, major strokes, and complications over time.
- Overall device success improved notably, with enhancements in patient outcomes attributed to advancements in technology and clinical practices in TAVI throughout the 15-year period.